Abstract: One or more electronic device may use motion and/or activity sensors to estimate a user's 6 minute walking distance. In particular, because users typically walk at less than their maximum output and in imperfect conditions, control circuitry within the device(s) may rely on walks of shorter distances to estimate the 6 minute walking distance. For example, the control circuitry may gather activity information for the user, such as heart rate, calories burned, and step count, and analyze a distance component and a speed component for periods in which the user has walked. Individual 6 minute walk distance estimates may be generated based on each of the activity information, distance component, and speed component. The distance and speed estimates may be corrected for walking behaviors that deviate from an ideal testing environment, and may then be fused with the activity estimate to generate a final 6 minute walk distance estimate.

Abstract: Embodiments are disclosed for identifying poor cardio metabolic health using sensors of wearable devices. In an embodiment, a method comprises: obtaining estimates of maximal oxygen consumption of a user during exercise; determining at least one confidence weight based on context data; adjusting the maximal oxygen consumption estimates using the at least one confidence weight; aggregating the adjusted maximal oxygen consumption estimates to generate a summary maximal oxygen consumption estimate and corresponding confidence interval for the user; and classifying cardiorespiratory fitness of the user based on at least one of the summary maximum consumption estimate, the corresponding confidence interval, a population error model or a low cardiorespiratory fitness threshold.

Abstract: One or more electronic device may use motion and/or activity sensors to estimate a user's maximum volumetric flow of oxygen, or VO2 max. In particular, although a correlation between heart rate and VO2 max may be linear at high heart rate levels, there is not a linear correlation at lower heart rate levels. Therefore, for users without extensive workout data, the motion sensors and activity sensors may be used to determine maximum calories burned by the user, workout data, including heart rate data, and body metric data. Based on these parameters, a personalized relationship between the user's heart rate and oxygen pulse (which is a function of VO2) may be determined, even with a lack of high intensity workout data. In this way, a maximum heart rate and therefore a VO2 max value may be approximated for the user.

Abstract: Novel water stable pharmaceutical compositions, their liquid form oral pharmaceutical compositions and kits thereof, rehydration beverages containing these water stable pharmaceutical compositions methods of manufacture and methods of use thereof are disclosed. The novel aqueous delivery systems are useful, inter alia, as alternative pharmaceutical dosing agents to tablets, capsules and other forms of delivering medication to a mammalian host in need thereof.

Abstract: Novel water stable pharmaceutical compositions, their liquid form oral pharmaceutical compositions and kits thereof, rehydration beverages containing these water stable pharmaceutical compositions methods of manufacture and methods of use thereof are disclosed. The novel aqueous delivery systems are useful, inter alia, as alternative pharmaceutical dosing agents to tablets, capsules and other forms of delivering medication to a mammalian host in need thereof.

Abstract: Novel water stable pharmaceutical compositions, their liquid form oral pharmaceutical compositions and kits thereof, rehydration beverages containing these water stable pharmaceutical compositions methods of manufacture and methods of use thereof are disclosed. The novel aqueous delivery systems are useful, inter alia, as alternative pharmaceutical dosing agents to tablets, capsules and other forms of delivering medication to a mammalian host in need thereof.

Abstract: Novel water stable pharmaceutical compositions, their liquid form oral pharmaceutical compositions and kits thereof, rehydration beverages containing these water stable pharmaceutical compositions methods of manufacture and methods of use thereof are disclosed. The novel aqueous delivery systems are useful, inter alia, as alternative pharmaceutical dosing agents to tablets, capsules and other forms of delivering medication to a mammalian host in need thereof.

Abstract: Novel water stable pharmaceutical compositions, their liquid form oral pharmaceutical compositions and kits thereof, rehydration beverages containing these water stable pharmaceutical compositions methods of manufacture and methods of use thereof are disclosed. The novel aqueous delivery systems are useful, inter alia, as alternative pharmaceutical dosing agents to tablets, capsules and other forms of delivering medication to a mammalian host in need thereof.

Abstract: Novel water stable pharmaceutical compositions, their liquid form oral pharmaceutical compositions and kits thereof, rehydration beverages containing these water stable pharmaceutical compositions methods of manufacture and methods of use thereof are disclosed. The novel aqueous delivery systems are useful, inter alia, as alternative pharmaceutical dosing agents to tablets, capsules and other forms of delivering medication to a mammalian host in need thereof.